Insider · CIK 0001894425

Onyia Jude

Reports to the SEC for 2 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001894425

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-11	NBIXNEUROCRINE BIOSCIENCES INCA Award	Chief Scientific Officer	AAward	+3,587 sh	—	—	24,583
2026-09-11	NBIXNEUROCRINE BIOSCIENCES INCF Tax Payment	Chief Scientific Officer	FTax Payment	−1,936 sh	$156.22	−$302K	22,647
2026-08-04	NBIXNEUROCRINE BIOSCIENCES INCG Gift	Chief Scientific Officer	GGift	−2,409 sh	—	—	20,996
2026-06-09	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2026-06-05	NBIXNEUROCRINE BIOSCIENCES INCG Gift	Chief Scientific Officer	GGift	−2,441 sh	—	—	23,405
2026-06-01	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+11K sh	$84.74	+$932K	36,846
2026-06-01	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Scientific Officer	SSale	−11K sh	$160.25	−$1.76M	25,846
2026-06-01	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−11K sh	—	—	13,268
2026-05-27	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+11K sh	$84.74	+$932K	36,846
2026-05-27	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Scientific Officer	SSale	−11K sh	$155.53	−$1.71M	25,846
2026-05-27	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−11K sh	—	—	24,268
2026-02-20	NBIXNEUROCRINE BIOSCIENCES INCG Gift	Chief Scientific Officer	GGift	−3,110 sh	—	—	25,670
2026-02-13	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,690 sh	—	—	19,801
2026-02-13	NBIXNEUROCRINE BIOSCIENCES INCF Tax Payment	Chief Scientific Officer	FTax Payment	−1,452 sh	$124.12	−$180K	18,349
2026-02-13	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,717 sh	—	—	21,066
2026-02-13	NBIXNEUROCRINE BIOSCIENCES INCF Tax Payment	Chief Scientific Officer	FTax Payment	−1,466 sh	$124.12	−$182K	19,600
2026-02-13	NBIXNEUROCRINE BIOSCIENCES INCA Award	Chief Scientific Officer	AAward	+19.9K sh	—	—	39,535
2026-02-13	NBIXNEUROCRINE BIOSCIENCES INCF Tax Payment	Chief Scientific Officer	FTax Payment	−10.8K sh	$124.12	−$1.33M	28,780
2026-02-13	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,690 sh	—	—	5,380
2026-02-13	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,717 sh	—	—	2,717
2026-02-13	NBIXNEUROCRINE BIOSCIENCES INC · Stock OptionA Award	Chief Scientific Officer	AAward	+55.1K sh	—	—	55,119
2026-02-13	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitA Award	Chief Scientific Officer	AAward	+9,669 sh	—	—	9,669
2026-02-12	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,560 sh	—	—	18,537
2026-02-12	NBIXNEUROCRINE BIOSCIENCES INCF Tax Payment	Chief Scientific Officer	FTax Payment	−1,426 sh	$123.10	−$176K	17,111
2026-02-12	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,560 sh	—	—	7,681
2026-01-31	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+238 sh	—	—	16,119
2026-01-31	NBIXNEUROCRINE BIOSCIENCES INCF Tax Payment	Chief Scientific Officer	FTax Payment	−142 sh	$136.06	−$19.3K	15,977
2026-01-31	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−238 sh	—	—	0
2025-11-29	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+4,426 sh	—	—	18,129
2025-11-29	NBIXNEUROCRINE BIOSCIENCES INCF Tax Payment	Chief Scientific Officer	FTax Payment	−2,248 sh	$152.16	−$342K	15,881
2025-11-29	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−4,426 sh	—	—	0
2025-09-03	NBIXNEUROCRINE BIOSCIENCES INCG Gift	Chief Scientific Officer	GGift	−1,470 sh	—	—	13,703
2025-08-05	NBIXNEUROCRINE BIOSCIENCES INCG Gift	Chief Scientific Officer	GGift	−3,116 sh	—	—	15,173
2025-07-09	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+59.8K sh	$84.74	+$5.07M	78,108
2025-07-09	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Scientific Officer	SSale	−59.8K sh	$130.46	−$7.8M	18,289
2025-07-09	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−59.8K sh	—	—	35,268
2025-07-02	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+20.4K sh	$84.74	+$1.73M	38,651
2025-07-02	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Scientific Officer	SSale	−20.4K sh	$130.13	−$2.65M	18,289
2025-07-02	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−20.4K sh	—	—	95,087
2025-06-03	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+24K sh	—	—	24,000
2025-02-13	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,717 sh	—	—	18,278
2025-02-13	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Scientific Officer	SSale	−1,432 sh	$116.83	−$167K	16,846
2025-02-13	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,690 sh	—	—	19,536
2025-02-13	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Scientific Officer	SSale	−1,447 sh	$116.75	−$169K	18,089
2025-02-13	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,717 sh	—	—	5,434
2025-02-13	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,690 sh	—	—	8,070
2025-02-12	NBIXNEUROCRINE BIOSCIENCES INC · Stock OptionA Award	Chief Scientific Officer	AAward	+54.6K sh	—	—	54,645
2025-02-12	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitA Award	Chief Scientific Officer	AAward	+10.2K sh	—	—	10,241
2025-01-31	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+238 sh	—	—	15,687
2025-01-31	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Chief Scientific Officer	SSale	−126 sh	$152.97	−$19.3K	15,561

Recent filings

Accepted (ET)
Sep 154
Onyia Jude0001894425-26-000020
SEC(opens sec.gov)
Aug 54
Onyia Jude0001894425-26-000018
SEC(opens sec.gov)
Jun 114
Onyia Jude0001104659-26-072922
SEC(opens sec.gov)
Jun 94
Onyia Jude0001894425-26-000014
SEC(opens sec.gov)
Jun 24
Onyia Jude0001894425-26-000012
SEC(opens sec.gov)
May 294
Onyia Jude0001894425-26-000010
SEC(opens sec.gov)
Feb 234
Onyia Jude0001894425-26-000007
SEC(opens sec.gov)
Feb 174
Onyia Jude0001894425-26-000005
SEC(opens sec.gov)

Companies

Address

6027 EDGEWOOD BEND CT.

SAN DIEGO, CA, 92130